22Jan
Blog: Cooley’s 2020 Life Sciences M&A Year in Review
General Trends in Life Sciences M&A - If 2019 was the year of life sciences mega-deals, 2020 was the year of COVID-19, as the global pandemic permeated every aspect of the dealmaking landscape, with the life sciences sector being no exception. COVID-19 drove unprecedented levels of collaboration among biopharmaceutical companies seeking to develop a vaccine, leading to an accelerated research and development process that allowed not just one—but two—vaccines to be approved by the FDA in...
By:
Cooley LLP
Related
As anticipated, in one of the last decisions before the end of Member McFerran’s term, the NLRB iss...
Read More >
What Happened: • On May 7, 2019, Governor Jay Inslee of Washington State signed House Bill 1607 in...
Read More >
Q. I heard that job postings which impose a maximum experience requirement for external applicants ...
Read More >
Employers classifying workers in California as independent contractors face grave new concerns based...
Read More >
Q: What can I ask about in a pre-employment physical? A: The ADA requires that any substantive hea...
Read More >
On August 12, Governor Cuomo signed sweeping new legislation toughening and substantially broadening...
Read More >